The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Open accessAbstract
Diabetic nephropathy (DN) is the leading cause of end-stage renal failure and a major risk factor for cardiovascular mortality in diabetic patients. To evaluate the multiple pathogenetic factors implicated in DN, unbiased mRNA expression screening of tubulointerstitial compartments of human renal biopsies was combined with hypothesis-driven pathway analysis. Expression fingerprints obtained from biopsies with histological diagnosis of DN (n = 13) and from control subjects (pretransplant kidney donors [n = 7] and minimal change disease [n = 4]) allowed us to segregate the biopsies by disease state and stage by the specific expression signatures. Functional categorization showed regulation of genes linked to inflammation in progressive DN. Pathway mapping of nuclear factor-κB (NF-κB), a master transcriptional switch in inflammation, segregated progressive from mild DN and control subjects by showing upregulation of 54 of 138 known NF-κB targets. The promoter regions of regulated NF-κB targets were analyzed using ModelInspector, and the NF-κB module NFKB_IRFF_01 was found to be specifically enriched in progressive disease. Using this module, the induction of eight NFKB_IRFF_01–dependant genes was correctly predicted in progressive DN (B2M, CCL5/RANTES, CXCL10/IP10, EDN1, HLA-A, HLA-B, IFNB1, and VCAM1). The identification of a specific NF-κB promoter module activated in the inflammatory stress response of progressive DN has helped to characterize upstream pathways as potential targets for the treatment of progressive renal diseases such as DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Gilbert, R. E., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00721.x · Cited by 649
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Role of the NF-kB Pathway in the Pathogenesis of Human Disease States
Yamamoto, Y., & Gaynor, R. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363816 · Cited by 329
Neish, A. S., Read, M. A., Thanos, D., Pine, R., Maniatis, T., & Collins, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2558 · Cited by 298
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
Bohle, A., Wehrmann, M., Bogenschütz, O., Batz, C., Müller, G. A., & Müller, G. A. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80780-6 · Cited by 285
Cohen, C. D., Frach, K., Schlöndorff, D., & Kretzler, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00113.x · Cited by 264
Self-citationOhmori, Y., & Hamilton, T. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5235 · Cited by 246
Phillips, J., & Eberwine, J. H. (1996) · Methods · doi:10.1006/meth.1996.0104 · Cited by 245
Role of inflammation in diabetic complications
Navarro, J. F., & Mora, C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi155 · Cited by 227
Génin, P., Algarté, M., Roof, P., Lin, R., & Hiscott, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5352 · Cited by 215
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., de Lourdes Noronha, I., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 196
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy
Sakai, N., Wada, T., Furuichi, K., Iwata, Y., Yoshimoto, K., Kitagawa, K., Kokubo, S., Kobayashi, M., Hara, A., Yamahana, J., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.08.039 · Cited by 152
Kim, T. I., Yoon, J., Cho, H., Lee, W., Kim, J., Song, Y.-H., Kim, S. N., Yoon, J. H., Kim‐Ha, J., & Kim, Y.-J. (2005) · Nature Immunology · doi:10.1038/ni1159 · Cited by 129
Johnson, D. R., & Pober, J. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1322 · Cited by 125
Cohen, C. D., Klingenhoff, A., Boucherot, A., Nitsche, A., Henger, A., Brunner, B., Schmid, H., Merkle, M., Saleem, M. A., Koller, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511257103 · Cited by 125
Self-citationKinugawa, K., Shimizu, T., Yao, A., Kohmoto, O., Serizawa, T., & Takahashi, T. (1997) · Circulation Research · doi:10.1161/01.res.81.6.911 · Cited by 119
Frech, K., Danescu-Mayer, J., & Werner, T. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1140 · Cited by 103
Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions.
Yozai, K., Shikata, K., Sasaki, M., Tone, A., Ohga, S., Usui, H., Okada, S., Wada, J., Nagase, R., Ogawa, D., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004111011 · Cited by 85
RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects
Nakajima, K., Tanaka, Y., Nomiyama, T., Ogihara, T., Ikeda, F., Kanno, R., Iwashita, N., Sakai, K., Watada, H., Onuma, T., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.892 · Cited by 75
O’Connor, A. S., & Schelling, J. R. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.032 · Cited by 68
Woods, M., Wood, E. G., Bardswell, S. C., Bishop‐Bailey, D., Barker, S., Wort, S. J., Mitchell, J. A., & Warner, T. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.923 · Cited by 60
Koga, M., Otsuki, M., Kubo, M., Hashimoto, J., & Kasayama, S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199808)15:8<661::aid-dia645>3.0.co;2-g · Cited by 58
Vascular cell adhesion molecule-l expression in the renal interstitium of diabetic KKAy mice
Ina, K., Kitamura, H., Okeda, T., Nagai, K., Liu, Z. Y., Matsuda, M., & Fujikura, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00011-x · Cited by 39
NFκB activation is required for interferon regulatory factor‐1‐mediated interferon β induction
Kirchhoff, S., Wilhelm, D., Angel, P. E., & Häuser, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00308.x · Cited by 38
Cited by
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
Self-citationThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Metadata
- Authors
- Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., Nelson, P. J., Schlöndorff, D., Cohen, C. D., Kretzler, M., & for the European Renal cDNA Bank (ERCB) Consortium
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-11-01
- Volume
- 55
- Issue
- 11
- Pages
- 2993-3003
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2144774384
- Cited by
- 419
- References
- 28
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.